from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3513c/fadD18

LFCtreatmentdescriptionclass of inhibitor

1.814

Amikacinug/mL Amikacintranslation

1.224

Cap5-10ug/mL Capreomycintranslation

1.438

Rox10-50 ug/mL Roxithromycintranslation

1.071

SM2-5 ug/mL Streptomycintranslation

1.285

Tet5-10 ug/mL Tetracyclinetranslation

0.036

Rif0.2-5ug/mL Rifampicintranscription

-0.295

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.007

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.970

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.118

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.120

Clofazimine10-13 ug/mL Clofaziminerespiration

0.468

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.034

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.738

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.440

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.067

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.144

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.474

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.447

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.383

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.575

KCN5-20 ug/mL Potassium cyaniderespiration

0.942

NaN30.2-2 mM Sodium aziderespiration

-0.317

Nigericin50 uM Nigericinrespiration

-0.178

TRC10-150 ug/mL Triclosanrespiration

-1.333

TRZ10-25 ug/mL Thioridazinerespiration

0.547

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.642

menadione6-10 ug/mL Menadionerespiration

0.912

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.028

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.086

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.095

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.733

NRP_1Non-replicating persistence stage 1dosRassociated

0.088

Amp0.2mg/mL AmpicillincellWall

0.114

Cephalexin20-100 ug/mL CephalexincellWall

0.416

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.003

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.155

EMB10-20 ug/mL EthambutolcellWall

0.342

Eta12-40 ug/mL EthionamidecellWall

0.752

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.013

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.070

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.102

BZA0.12 mg/mL BenzamidearomaticAmides

-0.005

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.265

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.452

H2O24 mM hydrogen peroxideDNAdamaging

0.638

Levo10 ug/mL LevofloxacinDNAdamaging

-0.432

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.275

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.861

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.093

UVUV-irradiationDNAdamaging

1.168

ARP41-4 ug/mL Antitubercular compound ARP4?

0.255

Antimycin12.5-50 ug/mL Antimycin A?

0.406

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.093

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.184

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.599

PA8240.2-2 ug/mL PA-824?

-0.449

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.193

Verapamil50 uM Verapamil?

-0.069

mercaptoethanol2 mM 2-Mercaptoethanol?

0.607

methoxatin10-20 ug/mL Methoxatin?